Higher-riskArticle link

Talking with the Doctor About Antipsychotics and the Black Box Warning

This article helps you, as a family caregiver, have a clear, informed conversation with your loved one's doctor about antipsychotic medications. We explain what the FDA black box warning means, why it exists for dementia, and how to ask the right questions. You'll find concrete steps, phrases to use, and ways to partner with the doctor to make the safest decision for your person. You are not alone in navigating this—there are concrete things you can try.

Key points

  • Antipsychotics have a black box warning for increased risk of death and stroke in older adults with dementia—this must be discussed openly with the doctor.
  • There are zero FDA-approved medications for agitation in dementia; any antipsychotic use is off-label and requires careful consideration.
  • Always ask about the specific target behavior, the lowest effective dose, and the shortest duration before starting.
  • Non-drug approaches (like redirection, routine changes, and environmental adjustments) should be tried first and continued alongside any medication.
  • You have the right to ask for a second opinion or a referral to a geriatric psychiatrist or dementia behavior specialist.
  • Document the informed consent discussion: what was said, what risks were explained, and what you agreed to.

What Is the Black Box Warning and Why Does It Matter?

The FDA requires a 'black box warning' on antipsychotic medications—the strongest safety warning possible—because studies show these drugs increase the risk of death and stroke in older adults with dementia. This warning applies to both atypical antipsychotics (like risperidone, quetiapine, olanzapine) and older typical antipsychotics (like haloperidol). The increased risk is not small: in clinical trials, about 1 in 100 people died more often than those on placebo, mostly from heart-related events or infections. This does not mean the drugs are never appropriate, but it means they must be used with extreme caution, at the lowest effective dose, for the shortest possible time, and only after non-drug approaches have been tried.

Why Are Antipsychotics Prescribed for Dementia?

Antipsychotics are FDA-approved for conditions like schizophrenia and bipolar disorder, but in dementia they are used 'off-label' to manage severe behavioral symptoms such as aggression, agitation, hallucinations, or delusions that cause significant distress or danger. The key point is that there are zero FDA-approved medications specifically for agitation in dementia. So when a doctor prescribes an antipsychotic, it is a judgment call based on the severity of the behavior and the failure of other strategies. The decision should always be a shared one between you, the doctor, and (if possible) your loved one.

The Goal: Informed Consent and Shared Decision-Making

Because of the black box warning, the doctor should document an informed consent discussion with you as the family caregiver. This means they explain the risks, benefits, and alternatives, and you agree—or not—to proceed. If this conversation does not happen, you should ask for it. Many lawsuits have occurred when a patient died and the doctor had not discussed the black box warning with the family. Your role is to ask questions, understand the reasoning, and ensure that non-drug approaches are still being used alongside any medication. The goal is not to refuse all medications, but to use them wisely and only when truly necessary.

General caregiving information, not medical advice. Check medications and major care changes with your clinician.

Step-by-step

  1. Before the appointment, write down a brief description of the specific behaviors that concern you: when they happen, how often, what seems to trigger them, and what you have already tried (like redirection, calming activities, or changing the environment). This helps the doctor see the full picture.

  2. At the start of the visit, say something like: 'I know there is a black box warning on antipsychotics for people with dementia. Can we talk about what that means for my loved one?' This shows you are informed and invites an open discussion.

  3. Ask the doctor directly: 'What is the specific behavior you are trying to treat with this medication? Is it aggression, hallucinations, or something else?' Make sure the target symptom is clear and measurable.

  4. Ask: 'What non-drug approaches have we tried, and what else could we try before or alongside this medication?' The doctor should be able to suggest environmental changes, routine adjustments, or referral to a dementia behavior specialist.

  5. If the doctor recommends an antipsychotic, ask: 'What is the lowest effective dose we can start with, and for how long should we try it? How will we know if it is working or if we need to stop?' This sets clear expectations for monitoring.

  6. Ask about the specific risks for your loved one: 'Given their health conditions (like heart disease, diabetes, or Parkinson's), what are the particular risks we should watch for?' This personalizes the discussion.

  7. Request a follow-up plan: 'Can we schedule a check-in in two weeks to see how it is going and decide whether to continue, adjust, or stop?' This ensures the medication is not continued indefinitely without review.

  8. If you are unsure, say: 'I need some time to think about this. Can we try a non-drug approach for a week or two first, and then revisit the medication decision?' Most doctors will respect this request.

  9. Document the conversation: write down the date, what was discussed, the risks explained, and your decision. This protects everyone and ensures clarity.

What not to do

  • Do not assume the doctor will automatically mention the black box warning. Many do not, especially in busy practices. You must bring it up yourself.

  • Do not agree to a medication without understanding the specific target behavior. If the goal is vague (like 'to calm them down'), ask for a clearer goal.

  • Do not stop a medication abruptly without talking to the doctor. Sudden withdrawal can cause rebound agitation or other problems. Always discuss a tapering plan.

  • Do not rely solely on medication and stop using behavioral strategies. The most effective approach combines medication with ongoing non-drug techniques like redirection, calming routines, and environmental adjustments.

  • Do not assume that because a medication is prescribed, it is safe or necessary. Always ask about the risks, benefits, and alternatives.

Practical tools

  • The 'Three Questions' Script

    Write down and bring these three questions to the appointment: 1) 'What is the specific behavior we are targeting?' 2) 'What non-drug approaches have we tried, and what else can we try?' 3) 'What is the lowest dose and shortest duration we can use, and how will we monitor?' Having these written down helps you stay focused.

  • Behavior Tracking Log

    Keep a simple log for 3-7 days before the appointment. Note the date, time, behavior (e.g., hitting, yelling, pacing), what happened right before (trigger), and what you did that helped or did not help. This gives the doctor concrete data and shows you are proactive.

  • The 'Ask for a Second Opinion' Phrase

    If you feel pressured or unsure, say: 'I appreciate your recommendation. I would like to get a second opinion from a geriatric psychiatrist or a dementia behavior specialist before starting this medication. Can you help me with a referral?' This is your right and can lead to better care.

  • The 'Informed Consent' Checklist

    Before starting any antipsychotic, ensure the doctor has discussed: the black box warning, the specific risks for your loved one, the target behavior, the plan for lowest dose and shortest duration, the non-drug alternatives, and the follow-up schedule. Check these off during the conversation.

  • Medication Review Sheet

    Bring a list of all medications your loved one takes (including over-the-counter, supplements, and any PRN meds). Ask the doctor to review each one for potential interactions or side effects that might mimic or worsen dementia behaviors. Sometimes stopping a problematic drug is safer than adding a new one.

Discuss with your clinician

Ask the doctor: 'Given my loved one's specific health conditions (e.g., heart disease, diabetes, Parkinson's), what are the particular risks of this antipsychotic for them?'

Ask: 'Is there a safer alternative, such as an antidepressant (like citalopram or sertraline) or a mood stabilizer, that might help with agitation without the same black box warning?'

Ask: 'If we start this medication, what specific side effects should I watch for and report immediately (e.g., increased confusion, falls, stiffness, fever)?'

Ask: 'How long should we try this medication before deciding if it is effective? And what is the plan for tapering or stopping it?'

Ask: 'Can we try a non-drug approach first for a set period (e.g., two weeks) and then reassess?'

Related guides

Sources